TRxADE HEALTH, Inc. Amends Definitive Merger Agreement with Superlatus, Inc.
July 14, 2023 16:30 ET
|
Trxade Health, Inc.
NEW YORK, July 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, announced today that it entered into an amended and restated...
Superlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive Merger Agreement to Create a Global Strategic Platform for Food and Healthy Snack Marketplace and Distribution
June 30, 2023 08:05 ET
|
Trxade Health, Inc.
NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), a U.S.-based holding company of food products and distribution capabilities, announced today that it has signed a...
TRxADE HEALTH, Inc. Issues Correction to Press Release Announcing its Anticipated Combination with Superlatus, Inc. (Correction Notice)
June 23, 2023 16:40 ET
|
Trxade Health, Inc.
NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ:MEDS) (“TRxADE”), a pharmaceutical exchange platform, today announced a correction to its press release issued on Friday, June...
Superlatus, Inc. to Combine with TRxADE HEALTH, Inc., to Create a Global Food Consolidation Platform
June 23, 2023 08:05 ET
|
Trxade Health, Inc.
NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), a U.S.-based holding company of food products and distribution capabilities, has signed a binding letter of intent (the...
TRxADE Health, Inc.’s Board of Directors Approves Reverse Stock Split
June 21, 2023 12:36 ET
|
Trxade Health, Inc.
Lutz, Florida, June 21, 2023 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (Nasdaq: MEDS) (the “Company”), today announced that its board of directors has approved a 1-for-15 reverse stock split of its...
TRxADE HEALTH Reports First Quarter Gross Margin of 69% and Q1 2023 Financial Results
May 15, 2023 16:15 ET
|
Trxade Health, Inc.
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, May 15, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the “Company”), a...
TRxADE HEALTH Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial Results
November 07, 2022 16:30 ET
|
Trxade Health, Inc.
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, Nov. 07, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the...
Bonum Health™, LLC (a TRxADE HEALTH Company) Strikes Strategic Business-to-Business (B2B) Telemedicine Services Agreement with Insurance Brokerage Firm(s) for Small-to-Medium Business (SMB) Employer Groups
October 25, 2022 08:30 ET
|
Trxade Health, Inc.
TAMPA, FL, Oct. 25, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)(“TRxADE” or the “Company”) an integrated drug procurement, delivery, and healthcare platform, today announced that...
TRxADE HEALTH, INC. Taps Advisory Board Member and Leading Pharmaceutical Industry Expert, Mr. Jeff Newell, For its Board of Directors
October 03, 2022 09:15 ET
|
Trxade Health, Inc.
TAMPA, FL, Oct. 03, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by...
TRxADE HEALTH, Inc., Launches NEXT DAY Delivery Services Via TRxADE Prime Plus Program
August 30, 2022 08:30 ET
|
Trxade Health, Inc.
TAMPA, FL, Aug. 30, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)(“TRxADE” or the “Company”) an integrated drug procurement, delivery, and healthcare marketplace platform that connects...